Form 8-K - Current report:
SEC Accession No. 0001558370-24-003671
Filing Date
2024-03-21
Accepted
2024-03-21 09:00:28
Documents
56
Period of Report
2024-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nxtc-20240321x8k.htm   iXBRL 8-K 50866
2 EX-99.1 nxtc-20240321xex99d1.htm EX-99.1 64774
3 EX-99.2 nxtc-20240321xex99d2.htm EX-99.2 47467
4 GRAPHIC nxtc-20240321xex99d1001.jpg GRAPHIC 6578
5 GRAPHIC nxtc-20240321xex99d1002.jpg GRAPHIC 137469
6 GRAPHIC nxtc-20240321xex99d2g001.jpg GRAPHIC 198853
7 GRAPHIC nxtc-20240321xex99d2g002.jpg GRAPHIC 287472
8 GRAPHIC nxtc-20240321xex99d2g003.jpg GRAPHIC 119318
9 GRAPHIC nxtc-20240321xex99d2g004.jpg GRAPHIC 96561
10 GRAPHIC nxtc-20240321xex99d2g005.jpg GRAPHIC 189887
11 GRAPHIC nxtc-20240321xex99d2g006.jpg GRAPHIC 138453
12 GRAPHIC nxtc-20240321xex99d2g007.jpg GRAPHIC 220290
13 GRAPHIC nxtc-20240321xex99d2g008.jpg GRAPHIC 189676
14 GRAPHIC nxtc-20240321xex99d2g009.jpg GRAPHIC 169651
15 GRAPHIC nxtc-20240321xex99d2g010.jpg GRAPHIC 160073
16 GRAPHIC nxtc-20240321xex99d2g011.jpg GRAPHIC 158938
17 GRAPHIC nxtc-20240321xex99d2g012.jpg GRAPHIC 205384
18 GRAPHIC nxtc-20240321xex99d2g013.jpg GRAPHIC 124444
19 GRAPHIC nxtc-20240321xex99d2g014.jpg GRAPHIC 158334
20 GRAPHIC nxtc-20240321xex99d2g015.jpg GRAPHIC 231205
21 GRAPHIC nxtc-20240321xex99d2g016.jpg GRAPHIC 117217
22 GRAPHIC nxtc-20240321xex99d2g017.jpg GRAPHIC 187889
23 GRAPHIC nxtc-20240321xex99d2g018.jpg GRAPHIC 142369
24 GRAPHIC nxtc-20240321xex99d2g019.jpg GRAPHIC 101993
25 GRAPHIC nxtc-20240321xex99d2g020.jpg GRAPHIC 137310
26 GRAPHIC nxtc-20240321xex99d2g021.jpg GRAPHIC 99806
27 GRAPHIC nxtc-20240321xex99d2g022.jpg GRAPHIC 165542
28 GRAPHIC nxtc-20240321xex99d2g023.jpg GRAPHIC 150309
29 GRAPHIC nxtc-20240321xex99d2g024.jpg GRAPHIC 130235
30 GRAPHIC nxtc-20240321xex99d2g025.jpg GRAPHIC 100505
31 GRAPHIC nxtc-20240321xex99d2g026.jpg GRAPHIC 131710
32 GRAPHIC nxtc-20240321xex99d2g027.jpg GRAPHIC 88705
33 GRAPHIC nxtc-20240321xex99d2g028.jpg GRAPHIC 144420
34 GRAPHIC nxtc-20240321xex99d2g029.jpg GRAPHIC 98799
35 GRAPHIC nxtc-20240321xex99d2g030.jpg GRAPHIC 74127
36 GRAPHIC nxtc-20240321xex99d2g031.jpg GRAPHIC 229069
37 GRAPHIC nxtc-20240321xex99d2g032.jpg GRAPHIC 93760
38 GRAPHIC nxtc-20240321xex99d2g033.jpg GRAPHIC 225009
39 GRAPHIC nxtc-20240321xex99d2g034.jpg GRAPHIC 180201
40 GRAPHIC nxtc-20240321xex99d2g035.jpg GRAPHIC 128902
41 GRAPHIC nxtc-20240321xex99d2g036.jpg GRAPHIC 101205
42 GRAPHIC nxtc-20240321xex99d2g037.jpg GRAPHIC 102663
43 GRAPHIC nxtc-20240321xex99d2g038.jpg GRAPHIC 108174
  Complete submission text file 0001558370-24-003671.txt   8357016

Data Files

Seq Description Document Type Size
44 EX-101.SCH nxtc-20240321.xsd EX-101.SCH 4009
45 EX-101.DEF nxtc-20240321_def.xml EX-101.DEF 2852
46 EX-101.LAB nxtc-20240321_lab.xml EX-101.LAB 17908
47 EX-101.PRE nxtc-20240321_pre.xml EX-101.PRE 11818
59 EXTRACTED XBRL INSTANCE DOCUMENT nxtc-20240321x8k_htm.xml XML 5032
Mailing Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705
Business Address 9000 VIRGINIA MANOR ROAD, SUITE 200 BELTSVILLE MD 20705 240-399-4900
NextCure, Inc. (Filer) CIK: 0001661059 (see all company filings)

EIN.: 475231247 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38905 | Film No.: 24769658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)